XML 51 R30.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Details) (Hemerus Medical, LLC [Member], USD $)	Sep. 28, 2013	Mar. 30, 2013
Business Acquisition [Line Items]
Business acquisition, cash paid		$ 24,100,000
Asset class
Intangible assets	20,400,000
Goodwill	10,324,000
Fair value of net assets acquired	30,724,000
FDA Approval of SOLX [Member]
Business Acquisition [Line Items]
Contingent consideration, maximum		3,000,000
Future Sales of SOLX [Member]
Business Acquisition [Line Items]
Contingent consideration, maximum		$ 14,000,000

The total purchase price of the acquired entity. This includes cash paid to equity interest holders of the acquired entity, fair value of debt and equity securities issued to equity holders of the acquired entity, and transaction costs paid to third parties to consummate the acquisition.

+ References+ Details